Adenosine Deaminase (ADA) measurement in pleural fluid is a widely used, highly effective, and cost-efficient diagnostic tool, primarily for the diagnosis of Tuberculous Pleurisy (TP).
Key Concepts and Mechanism
Primary Utility: Pleural fluid ADA is particularly useful for differentiating tuberculous exudative pleural effusions from other causes, especially malignant or parapneumonic effusions.
Enzyme Source: As with other body fluids, ADA is an enzyme released predominantly by activated T-lymphocytes and macrophages.
Pathogenesis in TP: In tuberculous pleurisy, the Mycobacterium tuberculosis infection triggers a strong cell-mediated immune response in the pleural space. This leads to the accumulation of lymphocytes that release ADA, causing elevated levels in the pleural fluid.
Diagnostic Interpretation
Tuberculous Pleurisy (TP): Pleural fluid ADA levels are typically significantly elevated in TP.
Cut-off Value: While there can be slight variations, a commonly accepted and highly reliable cut-off value for suggesting TP is \ge 40 \text{ U/L} (or IU/L).
Note: Some studies use cut-offs between 30-60 \text{ U/L}, but 40 \text{ U/L} is most prevalent for high diagnostic accuracy.
Diagnostic Performance: At the \ge 40 \text{ U/L} threshold, pleural fluid ADA demonstrates high sensitivity (around 90-100%) and high specificity (around 85-95%) for diagnosing TP. This makes it an excellent rule-in and rule-out test for TP.
Low ADA (: A low ADA level makes the diagnosis of TP highly unlikely, especially in populations with low TB prevalence.